With Integration of Biovail Nearly Completed, Valeant Looks For More Deals In 2011
This article was originally published in The Pink Sheet Daily
Executive Summary
Valeant's price-conscious, opportunistic approach to business development and relentless pace of activity has enabled it to quadruple sales in three years and grow its top-line 7% in 2010.